Connecting Leaders From Every Stage of the Value Chain to Drive Advanced Therapy Development & Novel Biologics Processing
Getinge is pleased to participate in CELL 2026, a leading industry event that brings together experts from across the advanced therapies and bioprocessing value chain. The conference provides a platform for scientific exchange, collaboration, and discussion on the latest innovations supporting the development and manufacturing of next-generation cell therapies and biologics.
Bringing together researchers, developers, manufacturers, technology providers, and industry leaders, CELL 2026 explores emerging technologies, process optimization strategies, and the evolving landscape of advanced therapy development.
Meet the Getinge team to learn how our solutions support efficient, scalable, and compliant bioprocessing workflows, helping drive innovation from research through commercialization.